Jared S. Mackenzie

Jared S. Mackenzie

Auto-generated profile, based on publicly available information

Jared S. Mackenzie

Africa Health Research Institute, Durban, South Africa

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 December 2020 in EMBO Molecular Medicine
Verified
Journal Article
Open access
PDF file
BLBei Shi Lee
Bei Shi Lee
KHKiel Hards
Kiel Hards
CECurtis A Engelhart
Curtis A Engelhart
EHErik J Hasenoehrl
Erik J Hasenoehrl
NKNitin P Kalia
Nitin P Kalia
KPKevin Pethe
Kevin Pethe
The approval of bedaquiline has placed energy metabolism in the limelight as an attractive target space for tuberculosis antibiotic development. While bedaquiline inhibits the mycobacterial F 1 F 0 ATP synthase, small molecules targeting other components of the oxidative phosphorylation pathway have been identified. Of particular interest is Telacebec (Q203), a phase 2 drug candidate inhibitor of the cytochrome bcc:aa 3 terminal oxidase. A functional redundancy between the cytochrome bcc:aa 3 and the cytochrome bd oxidase protects M .  tuberculosis from Q203‐induced death, highlighting the attractiveness of the bd ‐type terminal oxidase for drug development. Here, we employed a facile whole‐cell screen approach to identify the cytochrome bd inhibitor ND‐011992. Although ND‐011992 is ineffective on its own, it inhibits respiration and ATP homeostasis in combination with Q203. The drug combination was bactericidal against replicating and antibiotic‐tolerant, non‐replicating mycobacteria, and increased efficacy relative to that of a single drug in a mouse model. These findings suggest that a cytochrome bd oxidase inhibitor will add value to a drug combination targeting oxidative phosphorylation for tuberculosis treatment.

30 November 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
JMJared S. Mackenzie
Jared S. Mackenzie
DLDirk A. Lamprecht
Dirk A. Lamprecht
RARukaya Asmal
Rukaya Asmal
JAJohn H. Adamson
John H. Adamson
KBKhushboo Borah
Khushboo Borah
Adrie J.C. SteynAdrie J.C. Steyn
Adrie J.C. Steyn
The approval of bedaquiline (BDQ) for the treatment of tuberculosis has generated substantial interest in inhibiting energy metabolism as a therapeutic paradigm. However, it is not known precisely how BDQ triggers cell death in Mycobacterium tuberculosis (Mtb). Using 13C isotopomer analysis, we show that BDQ-treated Mtb redirects central carbon metabolism to induce a metabolically vulnerable state susceptible to genetic disruption of glycolysis and gluconeogenesis. Metabolic flux profiles indicate that BDQ-treated Mtb is dependent on glycolysis for ATP production, operates a bifurcated TCA cycle by increasing flux through the glyoxylate shunt, and requires enzymes of the anaplerotic node and methylcitrate cycle. Targeting oxidative phosphorylation (OXPHOS) with BDQ and simultaneously inhibiting substrate level phosphorylation via genetic disruption of glycolysis leads to rapid sterilization. Our findings provide insight into the metabolic mechanism of BDQ-induced cell death and establish a paradigm for the development of combination therapies that target OXPHOS and glycolysis.

13 August 2021 in Antioxidants
Verified
Journal Article
Open access
PDF file
TKTafara Kunota
Tafara Kunota
MRMd Aejazur Rahman
Md Aejazur Rahman
BTBarry Truebody
Barry Truebody
JMJared S. Mackenzie
Jared S. Mackenzie
VSVikram Saini
Vikram Saini
Adrie J.C. SteynAdrie J.C. Steyn
Adrie J.C. Steyn
H2S is a potent gasotransmitter in eukaryotes and bacteria. Host-derived H2S has been shown to profoundly alter M. tuberculosis (Mtb) energy metabolism and growth. However, compelling evidence for endogenous production of H2S and its role in Mtb physiology is lacking. We show that multidrug-resistant and drug-susceptible clinical Mtb strains produce H2S, whereas H2S production in non-pathogenic M. smegmatis is barely detectable. We identified Rv3684 (Cds1) as an H2S-producing enzyme in Mtb and show that cds1 disruption reduces, but does not eliminate, H2S production, suggesting the involvement of multiple genes in H2S production. We identified endogenous H2S to be an effector molecule that maintains bioenergetic homeostasis by stimulating respiration primarily via cytochrome bd. Importantly, H2S plays a key role in central metabolism by modulating the balance between oxidative phosphorylation and glycolysis, and it functions as a sink to recycle sulfur atoms back to cysteine to maintain sulfur homeostasis. Lastly, Mtb-generated H2S regulates redox homeostasis and susceptibility to anti-TB drugs clofazimine and rifampicin. These findings reveal previously unknown facets of Mtb physiology and have implications for routine laboratory culturing, understanding drug susceptibility, and improved diagnostics.

28 July 2021 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
YCYi Cai
Yi Cai
EJEleni Jaecklein
Eleni Jaecklein
JMJared Mackenzie
Jared Mackenzie
KPKadamba Papavinasasundaram
Kadamba Papavinasasundaram
AOAndrew Olive
Andrew Olive
CSChristopher M Sassetti
Christopher M Sassetti
In order to sustain a persistent infection,Mycobacterium tuberculosis(Mtb) must adapt to a changing environment that is shaped by the developing immune response. This necessity to adapt is evident in the flexibility of many aspects ofMtbmetabolism, including a respiratory chain that consists of two distinct terminal cytochrome oxidase complexes. Under the conditions tested thus far, thebc1/aa3complex appears to play a dominant role, while the alternativebdoxidase is largely redundant. However, the presence of two terminal oxidases in this obligate pathogen implies that respiratory requirements might change during infection. We report that the cytochromebdoxidase is specifically required for resisting the adaptive immune response. While the bd oxidase was dispensable for growth in resting macrophages and the establishment of infection in mice, this complex was necessary for optimal fitness after the initiation of adaptive immunity. This requirement was dependent on lymphocyte-derived interferon gamma (IFNγ), but did not involve nitrogen and oxygen radicals that are known to inhibit respiration in other contexts. Instead, we found thatΔcydAmutants were hypersusceptible to the low pH encountered in IFNγ-activated macrophages. Unlike wild typeMtb, cytochromebd-deficient bacteria were unable to sustain a maximal oxygen consumption rate (OCR) at low pH, indicating that the remaining cytochromebc1/aa3complex is preferentially inhibited under acidic conditions. Consistent with this model, the potency of the cytochromebc1/aa3inhibitor, Q203, is dramatically enhanced at low pH. This work identifies a critical interaction between host immunity and pathogen respiration that influences both the progression of the infection and the efficacy of potential new TB drugs.

1 December 2022 in Communications Biology
Verified
Journal Article
Open access
PDF file
MAMohamed Ahmed
Mohamed Ahmed
JMJared Mackenzie
Jared Mackenzie
LTLiku Tezera
Liku Tezera
RKRobert Krause
Robert Krause
BTBarry Truebody
Barry Truebody
ALAlasdair Leslie
Alasdair Leslie
Mycobacterium tuberculosis (Mtb) is one of the most successful human pathogens. Several cytokines are known to increase virulence of bacterial pathogens, leading us to investigate whether Interferon-γ (IFN-γ), a central regulator of the immune defense against Mtb, has a direct effect on the bacteria. We found that recombinant and T-cell derived IFN-γ rapidly induced a dose-dependent increase in the oxygen consumption rate (OCR) of Mtb, consistent with increased bacterial respiration. This was not observed in attenuated Bacillus Calmette–Guérin (BCG), and did not occur for other cytokines tested, including TNF-α. IFN-γ binds to the cell surface of intact Mtb, but not BCG. Mass spectrometry identified mycobacterial membrane protein large 10 (MmpL10) as the transmembrane binding partner of IFN-γ, supported by molecular modelling studies. IFN-γ binding and the OCR response was absent in Mtb Δmmpl10 strain and restored by complementation with wildtype mmpl10. RNA-sequencing and RT-PCR of Mtb exposed to IFN-γ revealed a distinct transcriptional profile, including genes involved in virulence. In a 3D granuloma model, IFN-γ promoted Mtb growth, which was lost in the Mtb Δmmpl10 strain and restored by complementation, supporting the involvement of MmpL10 in the response to IFN-γ. Finally, IFN-γ addition resulted in sterilization of Mtb cultures treated with isoniazid, indicating clearance of phenotypically resistant bacteria that persist in the presence of drug alone. Together our data are the first description of a mechanism allowing Mtb to respond to host immune activation that may be important in the immunopathogenesis of TB and have use in novel eradication strategies.

2 June 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
TKTafara Kunota
Tafara Kunota
MRMd Aejazur Rahman
Md Aejazur Rahman
BTBarry E. Truebody
Barry E. Truebody
JMJared S. Mackenzie
Jared S. Mackenzie
VSVikram Saini
Vikram Saini
Adrie J.C. SteynAdrie J.C. Steyn
Adrie J.C. Steyn
H 2 S is a potent gasotransmitter in eukaryotes and bacteria. Host-derived H 2 S has been shown to profoundly alter M. tuberculosis ( Mtb ) energy metabolism and growth. However, compelling evidence for endogenous production of H 2 S and its role in Mtb physiology is lacking. We show that multidrug-resistant and drug-susceptible clinical Mtb strains produce H 2 S, whereas H 2 S production in non-pathogenic M. smegmatis is barely detectable. We identified Rv3684 (Cds1) as an H 2 S-producing enzyme in Mtb and show that cds1 disruption reduces, but does not eliminate, H 2 S production, suggesting the involvement of multiple genes in H 2 S production. We identified endogenous H 2 S to be an effector molecule that maintains bioenergetic homeostasis by stimulating respiration primarily via cytochrome bd . Importantly, H 2 S plays a key role in central metabolism by modulating the balance between oxidative phosphorylation and glycolysis, and functions as a sink to recycle sulfur atoms back to cysteine to maintain sulfur homeostasis. Lastly, Mtb -generated H 2 S regulates redox homeostasis and susceptibility to anti-TB drugs clofazimine and rifampicin. These findings reveal previously unknown facets of Mtb physiology and have implications for routine laboratory culturing, understanding drug susceptibility, and improved diagnostics.